In colocalisation analysis employing conditional analysis adjusting for rs11581607, evidence of shared causal variants across interleukin-23 receptor and pancreatic cancer risk associations persisted (PPH4 = 69.8%). Here, IL23R is linked to pancreatic neoplasm.